Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 7
1981 5
1982 7
1983 13
1984 16
1985 24
1986 13
1987 16
1988 38
1989 72
1990 90
1991 96
1992 107
1993 97
1994 119
1995 137
1996 131
1997 123
1998 122
1999 118
2000 128
2001 117
2002 125
2003 106
2004 109
2005 116
2006 119
2007 113
2008 113
2009 118
2010 117
2011 117
2012 130
2013 124
2014 127
2015 131
2016 102
2017 97
2018 83
2019 105
2020 105
2021 118
2022 86
2023 99
2024 90
2025 112
2026 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,959 results

Results by year

Filters applied: . Clear all
Page 1
Leuprolide Acetate for Puberty Suppression in Transgender and Gender Diverse Youth: A Comparison of Subcutaneous Eligard Versus Intramuscular Lupron.
Eitel KB, Hodax JK, DiVall S, Kidd KM, Salehi P, Sequeira GM. Eitel KB, et al. J Adolesc Health. 2023 Feb;72(2):307-311. doi: 10.1016/j.jadohealth.2022.09.017. Epub 2022 Nov 18. J Adolesc Health. 2023. PMID: 36404242
PURPOSE: To compare the efficacy of intramuscular Lupron and subcutaneous Eligard, two formulations of leuprolide, for puberty suppression in transgender and gender diverse (TGD) youth. ...There were 55 incidents of 1hrPost levels, 42 after Eligard and 13 after L …
PURPOSE: To compare the efficacy of intramuscular Lupron and subcutaneous Eligard, two formulations of leuprolide, for puberty …
Leuprolide-induced myopathy.
Van Gerpen JA, McKinley KL. Van Gerpen JA, et al. J Am Geriatr Soc. 2002 Oct;50(10):1746. doi: 10.1046/j.1532-5415.2002.50474.x. J Am Geriatr Soc. 2002. PMID: 12366635 No abstract available.
Hypersensitivity vasculitis associated with leuprolide (Lupron).
Gnanaraj J, Saif MW. Gnanaraj J, et al. Cutan Ocul Toxicol. 2010 Sep;29(3):224-7. doi: 10.3109/15569527.2010.487505. Cutan Ocul Toxicol. 2010. PMID: 20470239
Leuprolide (Lupron) is a synthetic analog of naturally occurring gonadotropin-releasing hormone (GnRH). ...Serum sickness has never been reported as a side-effect of leuprolide. Our case is the first case of serum sickness associated with leuprolide. W …
Leuprolide (Lupron) is a synthetic analog of naturally occurring gonadotropin-releasing hormone (GnRH). ...Serum sickness has …
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group.
Dlugi AM, Miller JD, Knittle J. Dlugi AM, et al. Fertil Steril. 1990 Sep;54(3):419-27. doi: 10.1016/s0015-0282(16)53755-8. Fertil Steril. 1990. PMID: 2118858 Free article. Clinical Trial.
The safety and efficacy of leuprolide acetate (LA) for depot suspension (Lupron depot; TAP Pharmaceuticals, North Chicago, IL), 3.75 mg versus placebo, in the treatment of pain associated with endometriosis was assessed in a randomized, double-blind, multicenter stu …
The safety and efficacy of leuprolide acetate (LA) for depot suspension (Lupron depot; TAP Pharmaceuticals, North Chicago, IL) …
The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization.
Padilla SL, Smith RD, Garcia JE. Padilla SL, et al. Fertil Steril. 1991 Jul;56(1):79-83. doi: 10.1016/s0015-0282(16)54421-5. Fertil Steril. 1991. PMID: 1906020 Free article. Clinical Trial.
STUDY OBJECTIVE: To evaluate the prognostic and therapeutic value of a Lupron (leuprolide acetate; Tap Pharmaceuticals, North Chicago, IL) screening test before ovarian stimulation for in vitro fertilization (IVF). ...Pattern C patients benefit from the luteal phase …
STUDY OBJECTIVE: To evaluate the prognostic and therapeutic value of a Lupron (leuprolide acetate; Tap Pharmaceuticals, North …
GnRH agonist Lupron (leuprolide acetate) pre-treatments prevent ovulation in response to gonadotropin stimulation in the clouded leopard (Neofelis nebulosa).
Pelican KM, Wildt DE, Howard JG. Pelican KM, et al. Theriogenology. 2006 Oct;66(6-7):1768-77. doi: 10.1016/j.theriogenology.2006.01.016. Epub 2006 Feb 28. Theriogenology. 2006. PMID: 16513161
Seven female clouded leopards were given two injections of Lupron (3.75 mg IM) 23 d apart, followed 44 d later by eCG and hCG. Daily fecal samples were collected from 60 d before Lupron to 60 d after hCG. Fecal metabolites of estrogen (E) and progesterone (P) were m …
Seven female clouded leopards were given two injections of Lupron (3.75 mg IM) 23 d apart, followed 44 d later by eCG and hCG. Daily …
Lupron-induced mania.
Rachman M, Garfield DA, Rachman I, Cohen R. Rachman M, et al. Biol Psychiatry. 1999 Jan 15;45(2):243-4. doi: 10.1016/s0006-3223(98)00206-6. Biol Psychiatry. 1999. PMID: 9951575
Treatment of the endometriosis with lupron induced a manic episode. RESULTS: The lupron-induced mania was successfully treated with a mood-stabilizing agent, lithium carbonate. CONCLUSIONS: Patients with a history of affective disorder may develop manic episodes whe …
Treatment of the endometriosis with lupron induced a manic episode. RESULTS: The lupron-induced mania was successfully treated …
Reverse Engineering the 1-Month Lupron Depot .
Zhou J, Hirota K, Ackermann R, Walker J, Wang Y, Choi S, Schwendeman A, Schwendeman SP. Zhou J, et al. AAPS J. 2018 Oct 2;20(6):105. doi: 10.1208/s12248-018-0253-2. AAPS J. 2018. PMID: 30280294
The 1-month Lupron Depot (LD) encapsulating water-soluble leuprolide in poly(lactic-co-glycolic acid) (PLGA) microspheres is a benchmark product upon which modern long-acting release products are often compared. ...The rigorous approach of reverse engineering descr …
The 1-month Lupron Depot (LD) encapsulating water-soluble leuprolide in poly(lactic-co-glycolic acid) (PLGA) microspheres is …
PEGylated leuprolide with improved pharmacokinetic properties.
Fu M, Zhuang X, Zhang T, Guan Y, Meng Q, Zhang Y. Fu M, et al. Bioorg Med Chem. 2020 Feb 15;28(4):115306. doi: 10.1016/j.bmc.2020.115306. Epub 2020 Jan 7. Bioorg Med Chem. 2020. PMID: 31926774
Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist widely used in androgen deprivation therapy for the treatment of advanced prostate cancer, suffers from a short circulating half-life like other peptide therapeutics. ...
Leuprolide, a gonadotropin-releasing hormone (GnRH) agonist widely used in androgen deprivation therapy for the treatment of advanced …
Enzalutamide with or without leuprolide in patients with high-risk biochemically recurrent prostate cancer: EMBARK post hoc analysis by age.
Shore ND, De Giorgi U, Kalac M, Tang Y, Croitoru R, Rosales M, Huynh MJ, de Jong IJ, Evans CP, Carcano FM, Freedland SJ. Shore ND, et al. Eur J Cancer. 2026 Jan;232:116110. doi: 10.1016/j.ejca.2025.116110. Epub 2025 Nov 15. Eur J Cancer. 2026. PMID: 41274168 Free article. Clinical Trial.
INTRODUCTION: The EMBARK trial demonstrated that enzalutamide leuprolide significantly improved metastasis-free survival (MFS) in patients with nonmetastatic castration-sensitive prostate cancer with high-risk biochemical recurrence (hrBCR). ...Patients were randomized ( …
INTRODUCTION: The EMBARK trial demonstrated that enzalutamide leuprolide significantly improved metastasis-free survival (MFS) in p …
3,959 results